Consistent with this observation is the finding that the Glu169Lys variant in JPH2, identified in patients with HCM and AF, reduces binding to RyR2, hereby increasing abnormal SR Ca2+ release events and the incidence of AF in Glu169Lys mutant mice (96). The gene discussed is JPH2; the disease is atrial fibrillation.